Trial Profile
Safety and efficacy of lacosamide mono therapy in subjects with partial (focal) epilepsies.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 May 2016
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 04 May 2016 New trial record